Atlas market file · Equity · Asia-Pacific
NeoPharm Co., Ltd.092730
- Last close
- 18550.00
- Change
- -0.27%
- 96-bar range
- 15590.00 – 22350.00
- As of
- 30 Jul 2026
NeoPharm Co., Ltd. is a listed company listed as 092730 on KRX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- KRX symbol identity
- Chart rail
- TradingView
- File state
- Public profile
092730
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
â–® up candle â–® down candle
Weekly outlook: the last 104 weekly closes (-12.91% over the window).
Source rail: Yahoo Finance chart API (092730.KQ). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for 092730. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
092730 public profile
Listed company. NeoPharm Co., Ltd. is connected to current market context, cited company sources and its retained research file.
NeoPharm Co., Ltd. trades as 092730 on KRX. NeoPharm Co., Ltd. (092730) has a latest verified close of 18550.00, down 0.27%, dated 30 Jul 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. 092730 stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
Market Wit preview
092730 can look like the whole story when the screen is moving. It is not. NeoPharm Co., Ltd. still has to sell, build, manage, finance, comply, retain customers, handle competitors, and turn public claims into something that survives contact with the accounts. NeoPharm Co., Ltd. is listed on KRX in Asia-Pacific with TradingView symbol KRX:092730 and public listing evidence. The honest opening stays with the operating record: what NeoPharm Co., Ltd. actually sells, what the filings and cash line show, and which disclosed number would move 092730 from a described claim to a proven one (source: public profile, https://atlas.freedomcore.io/stocks/092730/).
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for 092730.
What changed for NeoPharm Co., Ltd. today
NeoPharm Co., Ltd. (092730) is tracked as a listed company on KRX. The public profile anchors the symbol identity, region, chart route, and research-only context for the Asia-Pacific market before any daily source layer is added.
092730 is handled first as a equity file: identity, listing route, source trail, chart context, and the current limits of the public evidence set.
The deeper daily research layer expands only when fresh evidence changes the file. Until then, this page keeps the public profile, chart route, risks, catalysts, and research-only framing explicit instead of manufacturing movement for its own sake.
Sources & evidence · 1 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
092730 technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-29. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on 092730
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep 092730 research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
092730 FAQ
What is NeoPharm Co., Ltd. (092730)?NeoPharm Co., Ltd. (092730) has a latest verified close of 18550.00, down 0.27%, dated 30 Jul 2026. Use this page to check the price chart, company context,...
NeoPharm Co., Ltd. (092730) has a latest verified close of 18550.00, down 0.27%, dated 30 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for 092730?NeoPharm Co., Ltd. (092730) has a latest verified close of 18550.00, down 0.27%, dated 30 Jul 2026. It brings the latest available chart, company context, cited...
NeoPharm Co., Ltd. (092730) has a latest verified close of 18550.00, down 0.27%, dated 30 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. 092730 stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the 092730 page updated?The 092730 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows...
The 092730 public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for 092730?The 092730 file starts with KRX symbol identity and TradingView KRX:092730. The page separates verified market context from company evidence and shows open evidence...
The 092730 file starts with KRX symbol identity and TradingView KRX:092730. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on 092730?Yes. The workstation can open 092730, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open 092730, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this 092730 page investment advice?No. The 092730 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a...
No. The 092730 page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →